Black Diamond Therapeutics, Inc. (BDTX)
1.78
-0.08
(-4.30%)
USD |
NASDAQ |
Oct 30, 16:00
1.77
-0.01
(-0.56%)
After-Hours: 20:00
Black Diamond Therapeutics Total Liabilities (Quarterly) : 28.94M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.94M |
| March 31, 2026 | 28.62M |
| December 31, 2025 | 30.80M |
| September 30, 2025 | 31.58M |
| June 30, 2025 | 33.78M |
| March 31, 2025 | 34.73M |
| December 31, 2024 | 39.36M |
| September 30, 2024 | 40.47M |
| June 30, 2024 | 38.96M |
| March 31, 2024 | 38.22M |
| December 31, 2023 | 41.83M |
| September 30, 2023 | 38.06M |
| June 30, 2023 | 37.68M |
| March 31, 2023 | 37.39M |
| December 31, 2022 | 40.56M |
| September 30, 2022 | 47.18M |
| Date | Value |
|---|---|
| June 30, 2022 | 46.46M |
| March 31, 2022 | 46.92M |
| December 31, 2021 | 51.78M |
| September 30, 2021 | 55.18M |
| June 30, 2021 | 36.86M |
| March 31, 2021 | 32.51M |
| December 31, 2020 | 21.91M |
| September 30, 2020 | 19.09M |
| June 30, 2020 | 6.325M |
| March 31, 2020 | 7.539M |
| December 31, 2019 | 205.45M |
| September 30, 2019 | 120.53M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | 67.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 46.42M |
| Armata Pharmaceuticals, Inc. | 321.12M |
| Voyager Therapeutics, Inc. | 43.38M |
| Invivyd, Inc. | 37.80M |
| Elicio Therapeutics, Inc. | 23.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.03M |
| Shareholders Equity (Quarterly) | 96.09M |
| Debt to Equity Ratio | 0.1766 |
| Current Ratio | 7.284 |
| Net Debt Paydown Yield | 0.87% |